why choose us

First received: June 01, 2023

Clinical Trial: HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in Russia

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Breast Cancer

Study Type: OBSERVATIONAL


Official Title: A Multicenter Observational Retrospective Study of Therapeutic Approaches and Clinical Outcomes in Real Clinical Practice in Russian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Posit

Brief Summary: Planned study population consists of approximately 1,000 adult patients with HER2-positive mBC receiving anti-HER2 therapy in about 50 oncological centers (in each center it is expected to recruit about 20 patients) in different regions in order to provide representative study sample.Patients will be included consecutively from the least recent diagnosis (within defined time period).Planned retrospective follow-up period for 1 patient is a period starting from the date of mBC diagnosis until end study or until…

Read more